LOS ANGELES--(BUSINESS WIRE)--Aug. 7, 2006--CytRx Corporation (Nasdaq:CYTR - News), a biopharmaceutical research and development company engaged in the development of high value human therapeutics, today announced that Scott Wieland, Ph.D., Vice President of Clinical and Regulatory Affairs, will present a company overview at the California Stock Report's 2006 Southern California Investor Conference at 11:30 a.m. PT on Friday, August 11th at the Hyatt Regency in Irvine, California.
